Interpreting Xpert MTB/RIF Ultra in a High-Risk Tuberculosis Referral Cohort in Taiwan: Treatment-Associated Culture Discordance and Rifampicin-Indeterminate Results
Diagnostics · 04.11.2026 · 16 (21) · 3651
DOI: 10.3390/diagnostics16213651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 04.11.2026. Verfasst von Ming-Jr Jian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei 11490, Taiwan. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital.
Abstract (Originalsprache)
Background/Objectives: Interpretation of positive and indeterminate rifampicin (RIF) calls from Xpert MTB/RIF Ultra (Ultra) in previously treated, high-risk populations is poorly characterised.
Methods
We retrospectively analysed all 2271 Ultra records (2024) at Taiwan’s National Reference Mycobacteriology Laboratory, a high-risk referral cohort, against referring-laboratory culture and phenotypic drug-susceptibility testing (pDST), with line-probe assay (LPA) as a reflex test and treatment history defined by referral indication.
Results
Among 1662 culture-paired records, sensitivity was 91.7% and specificity 75.1%. Specificity was 92.7% in screening or risk-based referrals but 56.4% in previously or currently treated patients, who accounted for 84.8% of culture-negative Ultra-positive results. Positive predictive value fell from 89.3% (HIGH) to 36.2% (Trace). All 77 Trace results were RIF indeterminate (77 of 78 indeterminate calls). In 362 of 382 pDST-paired records with determinate calls, RIF sensitivity and specificity were 94.3% and 96.8%. Eight of 10 pDST-discordant resistance calls, none sequenced, were LPA-resistant. Reflex LPA was interpretable in 98.9% of resistance-detected records but in 19.2% of indeterminate records.
Conclusions
Low specificity was concentrated among previously or currently treated patients, and indeterminate calls reflected Trace detection. LPA supported most pDST-discordant resistance calls, whose mutational basis remains unconfirmed. Stewardship should reflect the limited yield of reflex LPA in paucibacillary specimens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Pathology, Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei 11490, Taiwan.
- Graduate Institute of Pathology and Parasitology, National Defense Medical University, Taipei 11490, Taiwan.
ORCID-Profile: Ming-Jr Jian, Tai-Han Lin, Cherng-Lih Perng, Hung-Sheng Shang
Förderung
- Tri-Service General Hospital
Zitieren
APA
Jian, M. J., Chung, H. Y., Lin, T. H., Chang, C. K., Perng, C. L., & Shang, H. S. (2026). Interpreting Xpert MTB/RIF Ultra in a High-Risk Tuberculosis Referral Cohort in Taiwan: Treatment-Associated Culture Discordance and Rifampicin-Indeterminate Results. Diagnostics, 16(21), 3651. https://doi.org/10.3390/diagnostics16213651
Vancouver
Jian MJ, Chung HY, Lin TH, Chang CK, Perng CL, Shang HS. Interpreting Xpert MTB/RIF Ultra in a High-Risk Tuberculosis Referral Cohort in Taiwan: Treatment-Associated Culture Discordance and Rifampicin-Indeterminate Results. Diagnostics. 2026;16(21):3651. doi:10.3390/diagnostics16213651
BibTeX
@article{Jian2026,
author = {Jian, Ming-Jr and Chung, Hsing-Yi and Lin, Tai-Han and Chang, Chih-Kai and Perng, Cherng-Lih and Shang, Hung-Sheng},
title = {Interpreting Xpert MTB/RIF Ultra in a High-Risk Tuberculosis Referral Cohort in Taiwan: Treatment-Associated Culture Discordance and Rifampicin-Indeterminate Results},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3651},
doi = {10.3390/diagnostics16213651}
}
EUVIMED